Boston Trust Walden Corp Purchases 313,689 Shares of Axcelis Technologies, Inc. (NASDAQ:ACLS)

Boston Trust Walden Corp increased its stake in shares of Axcelis Technologies, Inc. (NASDAQ:ACLS - Free Report) by 61.9% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 820,116 shares of the semiconductor company's stock after acquiring an additional 313,689 shares during the period. Boston Trust Walden Corp owned about 2.52% of Axcelis Technologies worth $57,302,000 as of its most recent filing with the SEC.

Several other large investors have also recently bought and sold shares of ACLS. Van ECK Associates Corp boosted its holdings in shares of Axcelis Technologies by 40.0% in the 3rd quarter. Van ECK Associates Corp now owns 23,751 shares of the semiconductor company's stock valued at $2,490,000 after buying an additional 6,786 shares during the last quarter. Royce & Associates LP lifted its stake in Axcelis Technologies by 157.1% in the third quarter. Royce & Associates LP now owns 273,671 shares of the semiconductor company's stock valued at $28,694,000 after acquiring an additional 167,235 shares during the last quarter. Harbor Capital Advisors Inc. grew its position in shares of Axcelis Technologies by 243.8% in the 3rd quarter. Harbor Capital Advisors Inc. now owns 60,328 shares of the semiconductor company's stock valued at $6,325,000 after acquiring an additional 42,779 shares during the period. Annex Advisory Services LLC increased its stake in shares of Axcelis Technologies by 72.0% during the 3rd quarter. Annex Advisory Services LLC now owns 12,226 shares of the semiconductor company's stock worth $1,282,000 after purchasing an additional 5,118 shares during the last quarter. Finally, FMR LLC raised its holdings in shares of Axcelis Technologies by 51.4% in the 3rd quarter. FMR LLC now owns 263,332 shares of the semiconductor company's stock valued at $27,610,000 after purchasing an additional 89,453 shares during the period. 89.98% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

ACLS has been the subject of a number of recent analyst reports. Needham & Company LLC reaffirmed a "hold" rating on shares of Axcelis Technologies in a research report on Friday, November 8th. Benchmark downgraded Axcelis Technologies from a "buy" rating to a "hold" rating in a report on Friday, November 8th. Finally, Craig Hallum dropped their price objective on shares of Axcelis Technologies from $115.00 to $105.00 and set a "buy" rating on the stock in a research report on Wednesday, January 15th. Three investment analysts have rated the stock with a hold rating and four have issued a buy rating to the company's stock. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $155.83.

Axcelis Technologies Price Performance

Axcelis Technologies stock traded down $1.64 during mid-day trading on Thursday, reaching $65.46. 895,315 shares of the company were exchanged, compared to its average volume of 523,867. The company has a fifty day simple moving average of $71.84 and a 200-day simple moving average of $90.09. The firm has a market cap of $2.13 billion, a PE ratio of 9.68, a PEG ratio of 2.48 and a beta of 1.52. The company has a debt-to-equity ratio of 0.04, a current ratio of 4.45 and a quick ratio of 3.29. Axcelis Technologies, Inc. has a 12 month low of $64.18 and a 12 month high of $158.61.

Axcelis Technologies Profile

Axcelis Technologies, Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and Asia Pacific. The company offers high energy, high current, and medium current implanters for various application requirements.